Department of Urology, University of Regensburg, Frundsbergstrasse 28, Strasslach, 82064, Germany.
High-intensity focused ultrasound (HIFU) is an emerging, noninvasive, local treatment of prostate cancer with 15 years of clinical experience, during which about 30,000 HIFU treatments have been performed worldwide. In this paper, we review relevant publications regarding the means by which new and old prostate cancer technologies are evaluated, the outcomes of HIFU by Ablatherm (EDAP TMS, Lyon, France), and the evolution currently underway regarding how prostate cancer is diagnosed and treated. We show the potential of HIFU to be used as local therapy for men with any stage of prostate cancer and how this additional therapeutic option can fit within the future armamentarium of a sequential multimodal therapy concept.
Written by:
Chaussy CG, Thüroff SF. Are you the author?
Reference: Curr Urol Rep. 2011 Mar 23. Epub ahead of print.
doi: 10.1007/s11934-011-0184-2
PubMed Abstract
PMID: 21431390
UroToday.com Prostate Cancer Section
